GSK (NYSE:GSK) is pursuing a focused oncology expansion built around hematologic malignancies, gynecologic cancers, lung ...

GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.  | GSK is ...

GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at ...

GSK said its Jideytro drug showed benefits for patients with a type of lung cancer in a clinical trial, a finding that could help the company seek approval for the medicine at an earlier stage of ...

GSK stock rose 0.4% after Berenberg upgraded to buy with a £22 target and GSK announced a $750M deal with Chimagen Biosciences for a multiple myeloma asset.

GSK's Specialty Medicines are driving growth, but an approaching HIV patent cliff is pushing the company to accelerate its ...

Analysts at Berenberg upgraded drugmaker GSK from 'hold' to 'buy' on Tuesday and lifted their target price on the stock from ...

GSK (LSE:GSK) was upgraded to “buy” from “hold” by Berenberg, with the broker raising its price target to £22 from £20 following an assessment of the drugmaker’s pipeline and recent ...

UK pharma major GSK today announced it has entered an agreement to acquire a potential best-in-class trispecific T ...

Haleon's dual-placement strategy for Advil and TUMS at CVS lifted first-quarter sales per store, and talks with Walmart are ...

UK pharma major GSK (LSE: GSK) has set out full survival data for risvutatug rezetecan, its B7-H3 targeted antibody-drug ...

GSK is paying $110 million upfront to Hutchmed in a deal worth up to $1.295 billion. Now in its fifth year, the MM+M Media Summit 2026 brings together trailblazers from across health media and pharma ...